Amanda J. Gerringer

University of North Carolina at Chapel Hill

MedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation”.

N-acetyltransferase (NAT) 1 and NAT2 enzyme activities drive interindividual variability in sulfamethoxazole N-acetylation

Drug Metabolism and Disposition(2025)10.1016/j.dmd.2025.100195

N/A

0DataRank · unranked

1 citations

Bethany D. Latham, Amanda J. Gerringer, Tyler Interrante, Corbin D. Jones, Tristan De Buysscher +3 more

Interindividual variability in imatinib metabolism in human liver microsomes and primary human hepatocytes: Impact of CYP2C8 and CYP3A phenotypes

Drug Metabolism and Disposition(2025)10.1016/j.dmd.2025.100196

N/A

0DataRank · unranked

0 citations

Pegah Montazeri, Raeanne M. Geffert, Amanda J. Gerringer, Tyler Interrante, Corbin D. Jones +4 more